• Publications
  • Influence
Guideline for management of the clinical T1 renal mass.
  • 1,512
  • 63
The changing natural history of renal cell carcinoma.
PURPOSE Our understanding of the natural history of renal cell carcinoma, the role of nephrectomy, the benefits of immunotherapy and the possibilities of new technologies are evolving and beingExpand
  • 819
  • 25
Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma.
PURPOSE To create a comprehensive algorithm that can predict postoperative renal cell carcinoma (RCC) patient outcomes and response to therapy. PATIENTS AND METHODS A prospective cohort study wasExpand
  • 512
  • 25
Improved prognostication of renal cell carcinoma using an integrated staging system.
PURPOSE To integrate stage, grade, and Eastern Cooperative Oncology Group (ECOG) performance status (PS) into a clinically useful tool capable of stratifying the survival of renal cell carcinomaExpand
  • 603
  • 23
Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice
Prostate cancer mortality results from metastasis to bone and hormone-independent tumor growth. Models to study these progressive changes are lacking. Here we describe the propagation of advancedExpand
  • 404
  • 23
Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience.
PURPOSE To analyze to what extent histologic subtype is of prognostic importance in renal cell carcinoma based on a large, international, multicenter experience. PATIENTS AND METHODS Four thousandExpand
  • 405
  • 21
Prognostic relevance of the mTOR pathway in renal cell carcinoma
The mammalian target of rapamycin (mTOR) pathway is up‐regulated in many human cancers, and agents targeting the mTOR pathway are in various stages of clinical development. The goal of the study wasExpand
  • 321
  • 21
Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
PURPOSE We better defined the benefits and morbidity of lymph node dissection in patients with localized renal cell carcinoma using the experience of patients treated at our institution. MATERIALSExpand
  • 269
  • 20
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
BACKGROUND The occurrence of positive surgical margins (PSMs) after partial nephrectomy (PN) is rare, and little is known about their natural history. OBJECTIVE To identify predictive factors ofExpand
  • 206
  • 18
  • PDF
Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
PURPOSE Metastatic renal cell carcinoma (RCC) has a poor prognosis and an unpredictable course. To date, there are no molecular markers which can reliably predict RCC outcome. We investigated whetherExpand
  • 634
  • 17
  • PDF